Journal of Cellular Biochemistry

Journal

Publication Venue For

  • Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.  119:6216-6230. 2018
  • Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.  119:3326-3337. 2018
  • Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion.  118:2968-2976. 2017
  • Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.  118:2285-2294. 2017
  • Combinatorial PX-866 and Raloxifene Decrease Rb Phosphorylation, Cyclin E2 Transcription, and Proliferation of MCF-7 Breast Cancer Cells.  117:1688-1696. 2016
  • Titanium with Nanotopography Induces Osteoblast Differentiation by Regulating Endogenous Bone Morphogenetic Protein Expression and Signaling Pathway.  117:1718-1729. 2016
  • The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation.  117:426-438. 2016
  • A Kinase-Independent Function of c-Src Mediates p130Cas Phosphorylation at the Serine-639 Site in Pressure Overloaded Myocardium.  116:2793-2803. 2015
  • Notch-1 Promotes Stemness and Epithelial to Mesenchymal Transition in Colorectal Cancer.  116:2517-2527. 2015
  • Nanotopography drives stem cell fate toward osteoblast differentiation through α1β1 integrin signaling pathway.  115:540-548. 2014
  • Breakpoint regions of ETO gene involved in (8; 21) leukemic translocations are enriched in acetylated histone H3.  114:2569-2576. 2013
  • SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.  114:589-598. 2013
  • The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer.  113:13-18. 2012
  • Interleukin-4 inhibits RANKL-induced NFATc1 expression via STAT6: A novel mechanism mediating its blockade of osteoclastogenesis.  112:3385-3392. 2011
  • Cellular stress induced by resazurin leads to autophagy and cell death via production of reactive oxygen species and mitochondrial impairment.  111:574-584. 2010
  • Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.  111:249-257. 2010
  • Ribonucleoprotein immunoprecipitation (RNP-IP): A direct in vivo analysis of microRNA-targets.  110:817-822. 2010
  • The cytologic criteria of malignancy.  110:795-811. 2010
  • Identification of nuclear structural protein alterations associated with seminomas.  108:1274-1279. 2009
  • Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression.  107:992-1001. 2009
  • Transgenic expression of n-3 fatty acid desaturase (fat-1) in C57/BL6 mice: Effects on glucose homeostasis and body weight.  107:809-817. 2009
  • Intricate gene regulatory networks of helix-loop-helix (HLH) proteins support regulation of bone-tissue related genes during osteoblast differentiation.  105:487-496. 2008
  • Genetic and epigenetic regulation in nuclear microenvironments for biological control in cancer.  104:2016-2026. 2008
  • Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion.  104:1684-1698. 2008
  • Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.  103:788-799. 2008
  • Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.  103:509-519. 2008
  • From fibroblasts to iPS cells: Induced pluripotency by defined factors.  105:949-955. 2008
  • Osteoprotegrin and the bone homing and colonization potential of breast cancer cells.  103:30-41. 2008
  • Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.  100:434-449. 2007
  • New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.  99:36-52. 2006
  • Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment.  97:1292-1299. 2006
  • Regulation of the p53 transcriptional activity.  97:448-458. 2006
  • Calcium/calmodulin signaling controls osteoblast growth and differentiation.  97:56-70. 2006
  • Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies.  96:897-905. 2005
  • Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.  96:716-727. 2005
  • Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.  96:795-809. 2005
  • SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.  94:720-730. 2005
  • Modulation of 1?,25-dihydroxyvitamin D3-membrane associated, rapid response steroid binding protein expression in mouse odontoblasts by 1?,25-(OH)2D3.  94:139-152. 2005
  • Binding of two nuclear factors to a novel silencer element in human dentin matrix protein 1 (DMP1) promoter regulates the cell type-specific DMP1 gene expression.  92:332-350. 2004
  • Breast cancer cells induce osteoblast apoptosis: A possible contributor to bone degradation.  91:265-276. 2004
  • Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1.  92:178-188. 2004
  • Modeled microgravity disrupts collagen I/integrin signaling during osteoblastic differentiation of human mesenchymal stem cells.  93:697-707. 2004
  • Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells.  91:232-242. 2004
  • Nuclear microenvironments support assembly and organization of the transcriptional regulatory machinery for cell proliferation and differentiation.  91:287-302. 2004
  • Intranuclear trafficking of transcription factors: Requirements for vitamin D-mediated biological control of gene expression.  88:340-355. 2003
  • Molecular imaging: New applications for biochemistry.  162-171. 2002
  • Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts.  84:324-334. 2001
  • Expression and regulation of RUNX2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts.  80:424-440. 2000
  • Nuclear matrix proteins as cancer markers.  80:136-141. 2000
  • Extracellular glucose influences osteoblast differentiation and c-jun expression.  79:301-310. 2000
  • Leukemia-associated AML1/ETO (8;21) chromosomal translocation protein increases the cellular representation of PML bodies..  79:103-112. 2000
  • Phosphatase activity in rat adipocytes: Effects of insulin and insulin resistance.  77:445-454. 2000
  • Phosphatase activity in rat adipocytes: effects of insulin and insulin resistance..  77:445-454. 2000
  • Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells..  77:265-276. 2000
  • Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.  78:8-23. 2000
  • In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells.  74:468-478. 1999
  • Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.  73:114-125. 1999
  • Signal transduction by transforming growth factor-β: A cooperative paradigm with extensive negative regulation.  111-122. 1998
  • CBFa(AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation.  69:353-363. 1998
  • Identification of Rad's effector-binding domain, intracellular localization, and analysis of expression in Pima Indians.  65:527-541. 1997
  • Regulation of nuclear oncogenes expressed in lung cancer cell lines.  62:218-227. 1996
  • Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats.  61:629-637. 1996
  • Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats..  61:629-637. 1996
  • Regulation of nuclear oncogenes expressed in lung cancer cell lines.  62:218-227. 1996
  • ACTIVATION AND REGULATION OF HUMAN DJC-MU-GENE SEGMENT REARRANGEMENT PRIOR TO SURFACE EXPRESSION OF THE B-CELL MARKER-CD19.  112-112. 1995
  • FUNCTIONAL AND PHENOTYPIC CHARACTERIZATION OF INFLUENZA VIRUS-SPECIFIC CD8+/CD45R0+ CTLS AND CORRELATION WITH IFN-GAMMA PRODUCTION.  304-304. 1995
  • INDUCTION AND REGULATION OF IMMUNE-RESPONSES TO BIOENGINEERED MUCOSAL VACCINES.  166-166. 1995
  • Rationale for the use of genistein‐containing soy matrices in chemoprevention trials for breast and prostate cancer.  59:181-187. 1995
  • SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin‐like region and the Ca2+‐binding EF‐hand.  57:341-350. 1995
  • Evaluation of biomarkers in breast and prostate cancer.  56:259-266. 1994
  • Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program.  56:32-54. 1994
  • Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.  56:270-277. 1994
  • UNIQUE STRUCTURAL FEATURES OF FACTOR D, A SERINE-PROTEASE OF HUMAN-COMPLEMENT.  161-161. 1994
  • CHARACTERIZATION AND ACTIVATION OF THE MURINE INTERLEUKIN-1-BETA (IL-1-BETA) CONVERTING ENZYME.  117-117. 1993
  • DEVELOPMENTAL REGULATION OF DH AND JH GENE SEGMENT REARRANGEMENT IN MAN.  220-220. 1993
  • REGULATION OF C-JUN PHOSPHORYLATION IN HEMATOPOIETIC-CELLS.  183-183. 1993
  • Estrogen receptor‐negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid.  53:394-404. 1993
  • Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN).  50:47-53. 1992
  • Candidate biomarkers for applications as intermediate end points of lung carcinogenesis.  50:183-186. 1992
  • Inhibition of virus‐induced cell fusion by apolipoprotein A‐I and its amphipathic peptide analogs.  45:224-237. 1991
  • Expression and regulation of pOb24 and lipoprotein lipase genes during adipose conversion.  43:103-110. 1990
  • Granulocyte-macrophage colony-stimulating factor augmentation of leukocyte effector cell function.  105:137-41. 1989
  • Partial characterisation of the high and low molecular weight forms of P388D1‐derived interleukin 1.  26:65-73. 1984
  • International Standard Serial Number (issn)

  • 0730-2312
  • Electronic International Standard Serial Number (eissn)

  • 1097-4644